 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
In April 2005, the FDA recommended that Pfizer Inc. withdraw Bextra, a prescription painkiller, from the market. Bextra, with active ingredient valdecoxib, was marketed as a relief for pain associated with osteoarthritis and rheumatoid arthritis in adults, as well as for discomfort associated with menstrual cycles. Individuals taking the drug experienced serious, and sometimes fatal, side effects. Bextra led to heart failure, liver damage and stomach ulcers that bled. The drug was also linked to a grave skin disease. The FDA had approved Bextra for distribution in the United States on November 16, 2001. A subsequent FDA News advisory directed consumers to stop taking Bextra and call a doctor immediately if they experience stomach ulcers, skin disorder or liver damage. Signs of ulcers include burning stomach pain, black bowel movements that look like tar, and vomit that looks like blood or coffee grounds.
Some of the warning signs of liver damage are nausea, vomiting, tiredness, loss of appetite, itching, yellow coloring of skin or eyes, “flu-like” symptoms and dark urine. If you have used or are using Bextra and have had any of these side effects or other side effects, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
